STAT+
Uncovering the Truth: Faux Price Transparency, MAGA MA Insights, and UnitedHealth’s Latest Data Breach
The pharmaceutical industry has been under scrutiny for years, especially regarding drug prices. In 2017, after President Trump took office, ... Read more
Breaking News: Vinay Prasad Leaves the FDA—What This Means for Public Health
Vinay Prasad, a key figure at the Food and Drug Administration (FDA), recently left his position amidst some heated discussions ... Read more
FDA Resumes Approval of Sarepta Therapeutics’ Duchenne Therapy for Younger Patients: What You Need to Know
The FDA has made a significant announcement regarding Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy. Effective Monday, the agency ... Read more
Sarepta Therapeutics’ Duchenne Therapy: What an FDA Official Says About Its Challenging Road to Market
Sarepta Therapeutics is facing tough challenges with its gene therapy for Duchenne muscular dystrophy, called Elevidys. This treatment is currently ... Read more
Sarepta Therapeutics Cuts One-Third of Workforce: What This Means for the Future of the Company
Sarepta Therapeutics has recently made significant cutbacks, laying off about 500 employees, which is more than one-third of its workforce. ... Read more
Discover How an Ohio Health System Revolutionized Sepsis Prediction with AI: Key Findings Revealed!
In Akron, Ohio, emergency rooms faced a tough situation in 2021. Summa Health, a local community health system with four ... Read more
